awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33845734-0DCE816A-4BEA-49F7-86BC-DDF771A761F2
Q33845734-0DCE816A-4BEA-49F7-86BC-DDF771A761F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33845734-0DCE816A-4BEA-49F7-86BC-DDF771A761F2
Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.
P2860
Q33845734-0DCE816A-4BEA-49F7-86BC-DDF771A761F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33845734-0DCE816A-4BEA-49F7-86BC-DDF771A761F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
441646a04f3b12af5c1a2d27c76dc3d14ae61ec1
P2860
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial